Robin Mathew

Robin Mathew serves as the Associate Director of Medical Sciences and North America Medical Affairs Leader at Kenvue, starting in January 2024. Prior to this role, Robin held multiple positions at Johnson & Johnson from March 2016 to February 2024, including Associate Director of Medical Science and Manager of Medical Clinical. Earlier experience includes a tenure as a Medical Affairs Consultant at ClinChoice and Program Lead for Translational Development-Oncology at Celgene, where Robin managed a solid tumor biomarker project. At Rutgers University, Robin contributed significantly as an Instructor in Cancer Metabolism and a Post Doctoral Research Investigator, achieving four landmark discoveries and 27 high-impact publications that garnered substantial federal funding. Robin earned a Ph.D. from the University of Mumbai, specializing in Atomic Energy at the Bhabha Atomic Research Center.